Jump to content

GlaxoSmithKline (GSK) share price: Q2 earnings preview


Recommended Posts

GlaxoSmithKline Q2 revenue is expected to show revenue growth from newer drugs partially offset by increased generic competition in older drugs.

TraderSource: Bloomberg
 
 Shaun Murison | Senior Market Analyst, Johannesburg | Publication date: Tuesday 27 July 2021 

When is GlaxoSmithKline earnings date?

The GlaxoSmithKline (GSK) earnings release date is scheduled for the 28 July 2021. The scheduled results will cover the groups second quarter and half-year earnings.

 

GSK results preview: What does the street expect?

While GlaxoSmithKline (in partnership with Sanofi Pasteur) look to stage three trials of their Covid-19 vaccine, the company has not yet released a vaccine to market. The global rollout of Covid-19 vaccines (by competitors) looks to have disrupted the course of other vaccine programmes in key markets such as the US and the UK for GSK.

Revenue for second quarter (Q2) 2021 is expected to be bolstered by sales of newer drugs in the respiratory and HIV segments, with a partial offset from older drugs which are finding increased competition through generic offerings.

In terms of the upcoming results, a mean of analyst estimates compiled by Refinitiv data arrive at the following:

How to trade the GlaxoSmithKline results

 

GlaxoSmithKline chartSource: Refinitiv

 

A Refinitiv poll of analyst ratings arrive have a long term consensus rating of ‘buy’ for GlaxoSmithKline with a target price $47.87.

GlaxoSmithKline (ADR) share price: technical analysis

 

GlaxoSmithKline (ADR) chartSource: IG

The share price of GlaxoSmithKline continues to trade in an uptrend which has been in place since the beginning of March 2021. The price has however started to correct from near term highs.

The correction sees the price now testing support at the 38.85 level. Traders looking for long entry might prefer to see a bullish price reversal around current levels accompanied by a sharper move out of oversold territory by the Stochastic oscillator. In this scenario, the recent high at 40.55 would become the initial resistance target, while a close below 38.35 could be used as a stop loss consideration for the trade.

However should a bullish price reversal not manifest and we see the price move to close below both the 38.85 and 38.35 support levels, this could instead be a suggestion that the uptrend has failed and perhaps a new downtrend for the share price is forming.

In Summary

  • GSK reports Q2 2021 results on the 28 July
  • Q2 revenue of $10.433 billion (+10.27% YoY) is expected
  • Q2 EBITDA of $2.855 billion (-8.91% YoY) are expected
  • EPS $0.51 (+10.87% YoY) in the Q2 are expected
  • The average long term broker rating for GSK is a ‘buy’
  • The share price of GSK is testing support as it finds itself in a short-term correction of a longer-term uptrend
Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • General Statistics

    • Total Topics
      23,635
    • Total Posts
      97,041
    • Total Members
      44,195
    • Most Online
      7,522
      10/06/21 11:53

    Newest Member
    AKadri
    Joined 06/12/23 14:47
  • Posts

    • Johnson & Johnson, Elliott Wave Technical Analysis Johnson & Johnson, (JNJ:NYSE): 4h Chart 6 December 23 JNJ Stock Market Analysis: We changed the count to a bullish scenario. At this stage we are looking for upside in either a wave 3 or C that seems to be unfolding as expected. Looking for 5 waves within wave 3/C. JNJ Elliott Wave Count: Wave (iii) of {iii}.   JNJ Technical Indicators: Above all averages. JNJ Trading Strategy: Looking for longs into wave 3.   TradingLounge Analyst: Alessio Barretta           Johnson & Johnson, JNJ: 1-hour Chart 6 December 23 Johnson & Johnson, Elliott Wave Technical Analysis JNJ Stock Market Analysis: Looking for a sideways consolidation into wave (iv) to then continue higher as we seem to be finding support on 158$. Upside target for wave {iii} stands at 161.5 as we have 2.618 of {iii} vs. {i}. JNJ Elliott Wave count:  Wave (iv) of {iii} JNJ Technical Indicators: Above all averages. JNJ Trading Strategy: Looking for longs into wave (v).    
    • EURUSD Elliott Wave Analysis Trading Lounge Day  Chart, 6 December 23 Euro/U.S.Dollar(EURUSD) Day Chart EURUSD Elliott Wave Technical Analysis Function:  Counter Trend Mode: impulsive as A   Structure:blue wave 2 of A Position: Y of wave 2/B Direction Next lower Degrees: blue wave 3 of A   Details:After blue wave 1 now blue wave 2 as a correction started  . Wave Cancel invalid level: 1.10192 The "EURUSD Elliott Wave Analysis Trading Lounge Day Chart" for 6 December 23, delves into the Euro/U.S. Dollar (EURUSD) pair within a daily timeframe, employing Elliott Wave analysis to provide traders with a comprehensive view of market dynamics. Identified as a "Counter Trend" analysis, the focus is on potential reversals against the prevailing market trend. This is crucial for traders aiming to capitalize on corrective movements or trend changes. The analysis characterizes the current market "Mode" as "impulsive as A," signifying that the observed price action is impulsive and falls within the context of an A-wave in the Elliott Wave structure. Impulsive movements are typically strong and directional, often marking the initiation of a new trend. The primary "Structure" is labeled as "blue wave 2 of A," detailing the current phase within the Elliott Wave framework. Understanding the wave structure is fundamental for traders to gauge the market's position in the broader cycle. The specified "Position" is denoted as "Y of wave 2/B," indicating the current wave count within the larger degree of correction. This level of detail assists traders in comprehending the intricacies of the ongoing correction. The directional guidance for "Next Lower Degrees" is projected as "blue wave 3 of A," suggesting an anticipation of the next impulsive wave within the overarching correction. This information is valuable for traders seeking alignment with the expected market direction. In terms of "Details," the analysis notes that "After blue wave 1, now blue wave 2 as a correction started." This informs traders that the market is currently undergoing a corrective phase following the completion of the first impulsive wave. The "Wave Cancel invalid level" is identified as "1.10192," serving as a critical threshold. If the market reaches this level, it would invalidate the current wave count, prompting a reconsideration of the prevailing market conditions. To summarize, the EURUSD Elliott Wave Analysis for the day chart on 6 December 23, presents a counter-trend impulsive movement labeled as "wave 2 of A." The analysis provides insights into the wave structure, position, expected next wave, and a crucial level for potential wave cancellation.    
×
×
  • Create New...
us